Guiding Principle for ASAP’s Open Access Policy

Open access (OA) refers to a set of policies that allow for research outputs to be distributed online, free of cost or other access barriers. ASAP’s mission is to create a future where meaningful collaboration, research-enabling resources, and data sharing give us the answers we need to understand, diagnose, and treat Parkinson’s disease. By supporting an OA policy, we facilitate the rapid and free exchange of scientific ideas, ensuring that the research we fund can be leveraged for future discoveries.

Key Components of the ASAP Open Access Policy

In 2020, ASAP became a member of cOAlition S, a group of like-minded funders committed to steering the scientific establishment toward fully open practices. As a member, we require that all of our grantees are compliant with the key principles of Plan S, the OA implementation plan authored by cOAlition S).

Although Plan S went into effect starting January 1, 2021, ASAP is allowing researchers and publishers additional time to become fully compliant; our OA policy will be implemented through a step-wise process and will go into full effect on January 1, 2022.

There are five key components to ASAP’s OA policy:

  1. Immediate free online access upon publication with grantees retaining copyright via CC BY 4.0 license (or equivalent) for unrestricted reuse.
  2. Manuscripts posted in an OA preprint repository upon submission to a journal for review (or sooner). 
  3. All research outputs (data, protocols, code) deposited in publicly accessible repositories and cited in the publication. 
  4. Appropriate attributions to ASAP funded work.
  5. Utilizing our Research Output Management System (ROMS) to track research outputs within the ASAP virtual grantee platform  known as the ASAP Hub. 

All work published with partial or full support by ASAP must be credited and published according to ASAP’s OA policies. Only grantees that are fully compliant with our OA policy will be considered in requests for follow-on funding requests.

ASAP requires that all publications adhere to the following:

  • Immediate free access: Peer-reviewed, author accepted research must be made freely available immediately upon publication, without any embargo period (zero embargo).
  • Unrestricted reuse rights: Articles must be published under the Creative Commons Attribution license CC BY 4.0, or under the CC0 license which does not require attribution, or equivalent. Both licenses permit reuse of the material without restriction.

If other funders of a multi-funded grant (which ASAP also partially supports) are concerned about adhering to our policy, ASAP will engage in discussion with the other funder(s) to understand their concerns. Contact us at grants@parkinsonsroadmap.org to initiate discussion. Grantee compliance with our OA policies will be monitored vigilantly so we urge such discussion prior to publication when there are contravening circumstances. Below are details on how to comply with our requirements.

How to ensure immediate free access?

This guidance is designed to permit publication in any journal of choice while complying with our requirements of immediate free access to and unrestricted use of your original research publication.

  • Route 1 (preferred): Publish in a gold or hybrid journal that offers immediate OA of the final edited version of the journal article (known as the version of record [VoR]) and accepts a CC BY or equivalent license. Most gold and hybrid journals also accept the CC BY license. If they do not, it will be necessary to follow Route 2.
    • Gold journals provide immediate OA for all articles.
    • Hybrid journals provide OA for an additional fee on some articles but do not allow all their articles to be freely accessible.
  • Route 2 (discouraged): Publish in a subscription-only journal and deposit the Author Accepted Manuscript (AAM; the version following peer review that is accepted by the journal) in Pubmed Central under a CC BY license. Under this option (known as the “green” option), the AAM must be available to the public immediately upon the journal’s publication of the VoR (the final citable publication). Note that a few hybrid journals do not accept the CC BY license, in which case you’ll need to follow this route.  Route 2 is less desirable because the AAM does not reflect copyedited revisions, updates, or corrections to the paper. However, the AAM can be linked to the VoR for those who wish to read or cite the canonical version. If you are considering this route, please email grants@parkinsonsroadmap.org to discuss why Route 1 is not possible.

Note, that in our funding considerations, we will consider the intrinsic merit of the work, not the title or journal impact factor (JIF) of the journal or publisher. This is in line with the San Francisco Declaration on Research Assessment (DORA), of which we are a signatory.

ASAP support: coverage of reasonable Article Processing Charges (APCs)

To assist with compliance, ASAP will pay reasonable Article Processing Charges (APCs) in gold journals. ASAP will also cover the costs of publishing in hybrid journals in 2021. Starting in 2022, only hybrid journals that are declared “transformative” will be supported. Transformative journals are hybrid journals that have committed to being fully open access and are transitioning their publishing model to do so. cOAlition S tracks transformative journals and they are listed here

ASAP works with our implementation partner, The Michael J Fox Foundation (MJFF), to provide coverage when applicable for APCs. To apply for coverage, grantees can complete an online form at www.michaeljfox.org/openaccessfunds.

When the request is submitted, you will receive an email from the ASAP team, through MJFF, confirming receipt.  The ASAP team will review your request within 3-4 business days and notify you via email of the decision regarding the request. We may reach out for additional information needed to facilitate the review. The timeline for review may extend depending on your response time and the quality of additional information provided. Once you’ve received a positive decision on your request, you can forward to the ASAP team the notification from the publisher that payment is due upon final editorial acceptance of the paper. This will probably include a link to request a payment invoice.  We can then begin the process of requesting a payment invoice from the publisher to MJFF and arrange for payment directly to them on your behalf.  As a final step, we will send you a copy of the confirmation of the payment we received from the publisher. 

How to ensure appropriate CC license for unrestricted reuse rights?

For any publication, you must apply a Creative Commons (CC) Attribution license or public domain license to all Author Accepted Manuscripts (AAMs) arising from submissions to peer-reviewed journals that report original research. Below are the types of licenses that are compliant with ASAP’s open access requirement.

  • CC BY 4.0 is the default license required for all research papers. The license ensures that you receive attribution for the work (intellectual ownership) but allows your work to be freely shared (redistributed in any medium or format or adapted for future purposes).
  • CC0 license is applied to authors employed by the government, or for other content in the public domain. Under this license, no attribution is required.
  • CC BY-ND can be applied in exceptional cases. Under a CC BY-ND license, no derivatives of the original content are permitted (i.e., the content remains unchanged). In these cases, you must email grants@parkinsonsroadmap.org prior to publication acceptance to explain the reasons for the exception. We will consider on a case-by-case basis.

In the rare event that there is disagreement with the publisher regarding the licensing requirement and immediate online access requirement, contact ASAP at grants@parkinsonsroadmap.org to assist. To ensure appropriate licensing, you must:

  • Include language that your submission carries a CC BY public copyright license (or CC0, CC BY-ND if appropriate) in the acknowledgement section of your submitted manuscript (to both the preprint server and the publisher). See “Acknowledgements” in Requirement 4 for required language.
  • Determine whether the journal will include the CC BY (or CC0, CC BY-ND) license in the published VoR (the final version of record published by the journal). Journals typically list the license terms of an article under a rights and permissions or a copyright tab. If you cannot find this information, you can also send an email to the publisher.
    • If the journal has the appropriate licensing, and the article is being published in an open access journal (gold or hybrid), do nothing. The journal will submit your article to PubMed Central (PMC) or Europe PMC upon publication.
    • If the journal does not have the appropriate licensing, and/or if the journal is subscription-only, submit the AAM to PubMed Central so that it appears at the same time the VoR is published. 

How to identify whether a journal has gold or “transformative” status compliant with ASAP’s OA policy?

cOALition S funders have developed the Journal Checker Tool (JCT), which is a directory of journals that are fully compliant with Plan S policies. This tool includes all gold and hybrid journals that are “transformative” (i.e., hybrid journals committed to becoming fully open access). cOAlition S has a list of declared transformative journals here. Because not all hybrid journals are in the JCT directory, it does not cover all ASAP-supported publications in 2021; however, in 2022 when the full Plan S policy is implemented by ASAP, the directory will reflect all of your choices. The directory will be continually updated according to publishers’ changing policies.

If there are any questions about a journal’s status — i.e., gold, hybrid, transformative, or subscription only — please email grants@parkinsonsroadmap.org for assistance.

Preprints, which are complete drafts of manuscripts yet to be formally peer reviewed, must be submitted to a public preprint server – such as bioRxiv or medRxiv – upon submission to a journal, or sooner. Preprint manuscripts must be identical to the version submitted for publication, linking to research outputs, and carrying the appropriate CC license as described above.

Upon publication of the peer-reviewed article, the preprint must link to it. Note that if you have published in a subscription journal that does not have open access options, then the preprint would link to the author-accepted manuscript which carries the CC BY or equivalent license posted in PubMed Central.

In addition to ensuring open access to preprints and published manuscripts, ASAP’s open access policy requires that funded researchers maximize the availability of research data and code underlying research findings.

At a minimum, the data that support research papers must be made available to other researchers in recognized community repositories at the time of preprint and manuscript submission, as well as any original software that is required to view datasets or to replicate analyses.

Underlying data encompass all primary data, associated metadata, and any additional relevant data necessary to understand, assess, and replicate the reported study findings. Note that data could include software, datasets, protocols, tools, and reagents used. This is critical to allow others to verify, reproduce, and reuse data in new ways. In addition, careful recording and management of data and code offer provenance and preservation for future inquiries.

These policies are aligned with existing industry best practices, including data availability policies required by several publishers.

Repository selection for underlying data and software

ASAP will provide a list of preferred data repositories for which all funded work should be deposited, and we will work with teams to identify the appropriate platforms. Please note that any data repository of your choosing must adhere to the following:

  • enable immediate open access to the underlying data upon posting of your preprint and submission of your manuscript to a journal;
  • allow reuse with licensing no more restrictive than Creative Commons Attribution 4.0 License (CC BY 4.0);
  • assign your dataset with a persistent and unique identifier, such as a DOI (digital object identifier) to facilitate linking and citation;
  • provide long-term storage and preservation, such as those that meet the ISO’s trustworthy digital repository standards.

For questions about recommended repositories, please email grants@parkinsonsroadmap.org.

Accessibility of protocols, tools, and reagents

Experimental protocols that are employed in ASAP-funded research must be made publicly available (and updated as needed) through a protocol sharing service such as protocols.io. ASAP will provide support to grantees in using the protocols.io platform. Sharing and discussing scientific methods is crucial to achieving credible, reproducible experimental research.

All tools or reagents that are funded by ASAP and/or result from ASAP awarded projects must be made readily available to the community as a means of supporting reproducibility and to enable further research. Accessible community repositories will be recommended, such as the Michael J. Fox Foundation (MJFF) Tools Program (for model systems, cell lines, vectors) and Addgene (for plasmids, DNA reagents, viruses). This requirement applies to cell lines, transgenic models, plasmids/clones, antibodies, and other reagents. For questions about recommended repositories, please email grants@parkinsonsroadmap.org.

All publications resulting from partial or full support by ASAP — either during the award, or after the funding period has ended — must be credited with reference to the grant ID of the project and a named affiliation to appear in the Author Information section for an ASAP-funded investigator.

Acknowledgements

The following language must be included in the acknowledgements section of the publication:

The study is funded by the joint efforts of The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Aligning Science Across Parkinson’s (ASAP) initiative. MJFF administers the grant (insert grant number) on behalf of ASAP and itself. This research was funded in whole or in part by Aligning Science Across Parkinson’s [Grant number] through the Michael J. Fox Foundation for Parkinson’s Research (MJFF). For the purpose of open access, the author has applied a CC BY [replace with CC0, CC BY-ND if appropriate] public copyright license to all Author Accepted Manuscripts arising from this submission. 

Author affiliations

We want to ensure that the public can track who ASAP funded grantees are, therefore we ask that ASAP is also included in author affiliations.

  • For the ASAP Collaborative Research Network – In addition to an investigator’s home institution, an ASAP-specific affiliation should be designated as such: Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD.
  • For the ASAP Global Parkinson’s Genetics Program (GP2) – In addition to an investigator’s home institution, a GP2-specific affiliation should be designated as such: Aligning Science Across Parkinson’s (ASAP) Global Parkinson’s Genetics Program (GP2), Bethesda, MD.

ASAP is developing a custom-built Research Outputs Management System (ROMS) to help grantees track research outputs using persistent identifiers. Our goal is to retain a catalogue of where ASAP research outputs are located so that we can enhance access to resources generated within our Network for the entire research community. Usage of the ROMS will be incorporated into end of year reports and factor into future follow-on funding decisions.

Contact us

If you have any questions, email grants@parkinsonsroadmap.org.

Note, these policies will ultimately be housed on the ASAP website in perpetuity and will be referenced as such in the award contract. This is a living document and will be updated accordingly.

Last updated: February 26, 2021